June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Myeloid cell specific deficiency of RORα exacerbates choroidal neovascularization and subretinal inflammation in mice
Author Affiliations & Notes
  • Neetu Kushwah
    Ophthalmology, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, United States
  • Chi-Hsiu Liu
    Ophthalmology, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, United States
  • Kiran Bora
    Ophthalmology, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, United States
  • Meenakshi Maurya
    Ophthalmology, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, United States
  • Madeline Pavlovich
    Ophthalmology, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, United States
  • Ye Sun
    Ophthalmology, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, United States
  • Jing Chen
    Ophthalmology, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Neetu Kushwah None; Chi-Hsiu Liu None; Kiran Bora None; Meenakshi Maurya None; Madeline Pavlovich None; Ye Sun None; Jing Chen None
  • Footnotes
    Support  This work was supported by NIH/NEI R01 grants (EY024963, EY028100 and EY031765) (to JC).
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 2950. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Neetu Kushwah, Chi-Hsiu Liu, Kiran Bora, Meenakshi Maurya, Madeline Pavlovich, Ye Sun, Jing Chen; Myeloid cell specific deficiency of RORα exacerbates choroidal neovascularization and subretinal inflammation in mice. Invest. Ophthalmol. Vis. Sci. 2023;64(8):2950.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Choroidal neovascularization (CNV) leads to visual decline in neovascular AMD, a leading cause of blindness in the elderly. Lipid-cholesterol metabolic pathway has been implicated in AMD pathology, precipitated by chronic non-resolving subretinal inflammation. Retinoic acid receptor-related orphan receptor alpha (RORα), a lipid-cholesterol sensing nuclear receptor has been implicated in neovascular AMD. Previously we found that systemic deficiency of RORα in Rorasg/sg mice worsened laser-induced CNV, with increased inflammation. Here, we investigated the role of myeloid cell-specific RORα deficiency during aging and in a laser-induced CNV model.

Methods : Aged systemic (Rorasg/sg) and myeloid specific RORα deficient (LysMCre/Rorafl/fl) mice were examined for fundus imaging with their respective wild type and flox controls. Immunohistochemistry was carried out in RPE/choroid flat mounts and cross sections to visualize microglia/macrophages. Young adult LysMCre/Rorafl/fl and flox control (Rorafl/fl) mice were characterized for laser-induced CNV. RPE/choroid flat mounts were stained with isolectin to examine CNV lesions at 7 days post laser. Mouse monocyte/macrophage cells (RAW 264.7) were treated with synthetic RORα inverse agonists (SR3335 and SR1001) to assess lipid uptake and lipogenic gene expression in vitro. Chromatin immunoprecipitation (ChIP) assay was performed with retinal lysate to identify RORα target genes.

Results : Aged Rorasg/sg and LysMCre/Rorafl/fl mice both showed significant increase in fundus lesions compared with their controls, with accumulation of lipid-enriched microglia/macrophages in the subretinal space. LysMCre/Rorafl/fl mice showed significant increase in CNV lesion size compared with flox controls. Moreover, RORα inhibition with synthetic inverse agonists enhanced macrophage lipid uptake of low-density lipoprotein in RAW 264.7 cells and substantially induced protein levels of PPARγ, a lipogenic gene. Direct binding of RORα to the promoter region of Pparg was confirmed with ChIP assay.

Conclusions : Our findings indicate that genetic deficiency of RORα in myeloid cells worsens subretinal inflammation during aging and exacerbates laser-induced CNV, in part by promoting macrophage lipid uptake and lipogenesis via PPARγ. Hence, RORα is a regulator of myeloid-mediated chronic subretinal inflammation and neovascularization in AMD.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×